Here we explore whether AURKA inhibition potentiates a response to MIBG therapy.<h4>Results</h4>Using an <i>in vivo</i> model of high-risk neuroblastoma, we demonstrated a marked combinatorial effect of <sup>131</sup>I-MIBG and alisertib on tumor growth. Here, AURKA is linked to neuroblastoma.